Warner Chilcott shareholders to sell shares
This article was originally published in Scrip
Certain of Warner Chilcott's institutional shareholders and management are to sell 20 million of the company's ordinary shares in a secondary equity offering to the public at a price of $22.25 per share. The company will not receive any proceeds but it will pay the expenses of the offering.
You may also be interested in...
BioNTech extends Pfizer partnership to cover COVID-19 vaccine development and distribution while Fosun Pharma takes Chinese rights.
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
Infographic: Scrip homes in on key figures for companies integrating major acquisitions or divesting significant parts of their business.